Your browser doesn't support javascript.
loading
Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy.
Zhou, Ying; Zhou, Jinmei; Hao, Xiaopeng; Shi, Haoyuan; Li, Xuejie; Wang, Anqi; Hu, Zhiyuan; Yang, Yanlian; Jiang, Zefei; Wang, Tao.
Afiliación
  • Zhou Y; Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Zhou J; CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.
  • Hao X; Breast Cancer Department, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Shi H; Department of General Surgery, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Li X; Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Wang A; CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.
  • Hu Z; Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Yang Y; CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.
  • Jiang Z; Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Wang T; CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, China.
Breast Cancer Res Treat ; 200(2): 281-291, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37227611
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Células Neoplásicas Circulantes Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares / Células Neoplásicas Circulantes Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: China